Disappointed over the “lack of clarity” in the U.S. Food and Drug Administration’s stance on potential approval of the company’s proposed chronic kidney disease (CKD) drug, Ardelyx will cut another 102 jobs, according to an SEC Filing.
If you are not happy with the results below please do another search
50 search results for:
Before Merck and Acceleron Pharma struck an $11.5 billion merger agreement in September 2021, rare disease-focused Acceleron was wooed by multiple suitors including pharma giant Bristol Myers Squibb, according to a report from Bloomberg.
Europe’s drug regulator started a real-time review of AstraZeneca’s antibody-based Covid-19 therapy, the first protective shot other than vaccines against coronavirus.
The COVID-19 pandemic altered the trajectory of healthcare, but what about healthcare marketing? As part of its Next series, IPG Health brought together experts from across the network and the industry to talk about the emerging trends and technologies that are accelerating innovation in health. FCB Health Chief Product Officer Graham Johnson discusses a few key trends that marketers should pay attention to in looking toward the future.
Vaccination rates against Covid-19 in the United States rose by more than 20 percentage points after multiple institutions adopted vaccine requirements, while case numbers and deaths from the virus are down, Biden administration officials said on Oct. 13.
People who got Johnson & Johnson’s Covid-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer/BioNTech or Moderna, a study run by the National Institutes of Health showed on Oct. 13.
The U.S. Food and Drug Administration is pushing to cut salt levels by an average of 12 percent in food ranging from packaged meats to cheese, trying to clamp down on a growing epidemic of preventable health issues that has plagued the country.
The U.S. Food and Drug Administration approved Merck’s anti-PD-1 therapy Keytruda in combination with chemotherapy, with or without bevacizumab, for the treatment of patients with persistent, recurrent or metastatic cervical cancer whose tumors express PD-L1 (Combined Positive Score [CPS] ≥1) as determined by an FDA-approved test.
The Ashfield Excellence Academy was formed to design, develop and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries.
Japan’s Takeda Pharmaceutical announced deals with two biotech companies, Seattle-based Immusoft and San Diego’s Poseida Therapeutics.